mutation was associated with a low disease penetrance and a benign prognosis. In contrast, the 403&5-G-n mutation in a Caucasian kindred was associated with a 100% disease penetrance and high incidence of sudden cardiac death. Recently, another mutation, 606v'l Met, has been reported to be associated with "near normal survival" and offered as evidence for the benign nature of neutral charge substitutions.
Methods and Results We report (1) a large kindred (245 family members at risk of inheriting the disease gene) with a 256iY0lIu mutation characterized by a similar disease penetrance in adults and in children (56% and 60%, respectively) and a cumulative sudden cardiac death rate of only 2% at 50 years of age, (2) a kindred with the 606V"-Met mutation with four sudden cardiac deaths in eight affected individuals, and (3) a Korean kindred with the 403A4-g GIn mutation. Although the disease occurred early and was associated with a high prevalence of myocardial ischemia in both of our kindreds with the 4031g91ii mutation, no sudden cardiac death or syncope has occurred in the Korean kindred. Furthermore, in the H pypertrophic cardiomyopathy (HCM) is a primary myopathy with an autosomal pattern of inheritance, characterized by increased left ventricular (LV) wall thickness in the absence of another cause for the increased cardiac mass. ' Patients with HCM are often symptomatic and are prone to arrhythmias and sudden cardiac death.'-" In some kindreds, the disease has been linked to the f-myosin heavy chain (3-MHC) gene locus on chromosome 14ql. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] In these kindreds, HCM has been associated with substitutions of single highly conserved amino acids in the head or head-rod junction of the ,B-MHC molecule. We have previously reported that clinical expression has differed significantly in two kindreds with distinct 3-IMHC gene mutations: The 908``u va1 mutation has been associated with low disease penetrance and a benign prognosis. '6 In contrast, the 403A4G1n mutation has been associated with expression of the phenotype in all individuals with the disease allele and a high 908``Uva and the 256GlY GIu mutations satisfy this requirement. ( 2) The 256G'Y`Iu mutation demonstrates that not all muta- tions that result in a charge change are malignant. (3) Conversely, the 606v`"Met mutation is malignant in some kindreds;
hence, despite the absence of a charge change, minor substitutions in critical regions of 3-myosin heavy chain protein may also have serious consequences. (4) The diverse ethnic origins of the two 403-g-GIn kindreds provide evidence suggesting that the identical mutation occurred independently and was associated with different genetic backgrounds. Their distinct phenotypes underline the importance of modifying genes and nongenetic factors. (Circulation. 1994;89: 22-32.) Key Words * hypertrophic cardiomyopathy * geneticssudden death * missense mutation * myosin heavy chain incidence of premature sudden cardiac death. '6,17 Re- cently, another mutation, 606VaI-Met, has been reported to be associated with "near normal survival" and is offered as evidence for the benign nature of neutral charge substitutions compared with ,-BMHC gene mutations that result in a charge change. ' were used to obtain two-dimensional images in a number of cross-sectional planes. The distribution of LV hypertrophy was assessed primarily in the parasternal short-axis plane, although parasternal long-axis apical two-and four-chamber views were also used to integrate the information obtained from the short-axis images. Because the 403"m`' mutation has been associated with a poor prognosis,16,17 patients with this mutation were evaluated additionally by radionucdide angiography, exercise thallium scintigraphy, cardiac catheterization, and electrophysiological study, as part of ongoing efforts to riskstratify HCM patients (study protocol 84-H-232). Details of these investigations have been reported previously. [30] [31] [32] [33] Determination of Genotype Po)ymerase chain reaction and Southern blot analysis. Each family member was phlebotomized, and DNA was extracted from isolated nuclei of peripheral white blood cells by procedures described previously. 34 
Results

Clinical Consequences of the 256G"G1u Mutation in Kindred 2280
We have reported the 256GY`u mutation previously. 38 To determine the phenotypic consequences of this mutation in kindred 2280, we evaluated 245 family members at risk of inheriting the 256G1Y' Gu mutation. A subset of this pedigree is depicted in Fig 1. The disease allele was demonstrated in 39 individuals: 34 adults (aged 23 to 82 years) and 5 children (aged 1 to 11 years). Three family members in whom the disease allele was absent were excluded from the study because of the presence of aortic valve disease (n=1) and atrial septal defect (n=2).
Disease penetrance. Fig 2 shows the relation between LV wall thickness as a function of age in individuals with the disease mutation and family members in whom the mutation was absent. The maximal LV wall thickness in 117 individuals aged 220 years in whom the disease allele was absent ranged from 4 to 14 mm. Notably, the maximal LV wall thickness was < 14 mm in 15 (44%) of the 34 adult individuals with the 256GIybG1u mutation and ranged from 15 to 27 mm in the remaining 19 individuals with the disease allele (Fig 2) . Table 3 . In several respects, the clinical findings were similar in both kindreds: (1) Disease penetrance was 100% in adults and children in both kindreds. (2) There was a high prevalence of myocardial ischemia (Fig 6) . (Tables 3  and 4 ). In all the remaining patients, symptoms of impaired consciousness (syncope and presyncope) were related to myocardial ischemia. Furthermore, the high incidence of sudden cardiac death in kindred 2002 was similar to that reported in a kindred with the identical 403Arg-$hln mutation (Table 3) patients in a large kindred with the 908ueu-Va1 mutation have marked cardiac hypertrophy, the disease penetrance has been low (63% in adults with the mutation), and the incidence of sudden cardiac death has been only 8% at 50 years of age. 16 The benign prognosis associated with the 908L'u-al mutation could be attributed to the absence of a charge change, and indeed, the 606Va-Met mutation has recently been reported to be associated with a low incidence of premature sudden cardiac death. This has been offered as evidence of the benign nature of neutral charge change mutations compared with missense mutations that result in a charge change, such as the 249Arg-Gn, 403Arg-1'n, and 453Arg-cys mutations (Fig 7) .17 However, the large number of premature sudden cardiac deaths in our kindred with the identical 606va'-Met mutation indicates that neutral charge change amino acid substitutions in critical regions of the /3-myosin molecule may be associated with a malignant prognosis in some kindreds. Furthermore, the 256G'Wy-GIu mutation demonstrates that not all mutations associated with a charge change have a poor prognosis (Fig 7) .
Determination of the genotype provides an opportunity for reexamining the definitions of cardiac hypertrophy in HCM. A finding of the present study with important implications for the diagnosis of HCM and estimation of disease penetrance is that, ideally, cardiac hypertrophy needs to be assessed not by reference to an arbitrary value of LV wall thickness but in the context of the cardiac dimensions of family members who do not have the disease allele. For 
